Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies? (2019)
Attributed to:
Differentiation of GMP-grade human embryonic stem cells to midbrain dopaminergic neurons for transplantation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/ejn.14314
PubMed Identifier: 30586214
Publication URI: http://europepmc.org/abstract/MED/30586214
Type: Journal Article/Review
Volume: 49
Parent Publication: The European journal of neuroscience
Issue: 4
ISSN: 0953-816X